NASDAQ · Biotechnology

Applied Molecular Transport Inc. (AMTI) Stock

$0.26 -3.13% NASDAQ: AMTI Healthcare

Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the clinical development phase, was founded in 2010 and is based in South San Francisco, California.

Valuation

MetricValue
Price$0.26
Market Cap$11.01M
P/E Ratio-0.08
P/B Ratio0.17
P/S Ratio0.00
EPS (TTM)$-3.23
52-Week High$0.84
52-Week Low$0.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-111.78%
ROA-116.74%
ROCE-137.74%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.59
Current Ratio4.24

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-30.0M$-28.0M$-67.0M$-101.0M$-127.0M
Net Profit$-30.0M$-28.0M$-64.0M$-96.0M$-125.0M
EPS$-1.70$-1.31$-2.82$-2.56$-3.23
Op Margin—————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$23.0M$39.0M$140.0M$214.0M$107.0M
Total Liabilities$67.0M$110.0M$9.0M$50.0M$47.0M
Cash$20.0M$13.0M$6.0M$160.0M$61.0M
Borrowings$0$0$1.0M$40.0M$36.0M

Latest News

OP Pohjola's President and Group CEO Timo Ritakallio has announced that he will retire on 1 July 2027 as specified in his executive contract GlobeNewswire · Jul 23, 2026 Constellation Brands Shareholders Approve Directors, Pay and Incentive Plan at Annual Meeting MarketBeat · Jul 23, 2026 OP Corporate Bank plc's Half-year Financial Report 1 January–30 June 2026 GlobeNewswire · Jul 23, 2026 Asia's Largest Sustainable Seafood Event "The Sustainable Seafood Summit 2026" to Be Held from October 21 to 23, with Key Stakeholders Attending in Person PR Newswire · Jul 23, 2026 AS Tallink Grupp Unaudited Consolidated Interim Report for the Q2 2026 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-27.0M$-27.0M$-59.0M$-83.0M$-94.0M
Investing Cash Flow$-1.0M$-24.0M$-115.0M$120.0M$-8.0M
Financing Cash Flow$31.0M$42.0M$161.0M$116.0M$0
Net Cash Flow$3.0M$-7.0M$-7.0M$155.0M$-99.0M
Free Cash Flow$-28.0M$-29.0M$-64.0M$-84.0M$-98.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.11
FCF Yield-890.87%
Quick Ratio4.24
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALNAAllena Pharmaceuticals, Inc. $0.08 +14.29% -0.08 $0 0.00%
APGNApexigen, Inc. $0.39 +8.48% -0.24 $9.57M 0.00%
BTHEBoston Therapeutics, Inc. $0.01 +0.00% -1.00 $0 0.00%
CHROChannel Therapeutics Corporation $1.35 +7.14% -0.05 $8.90M 0.00%
GLSGelesis Holdings, Inc. $0.16 +0.00% -0.20 $11.63M 0.00%

About Applied Molecular Transport Inc.

Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the clinical development phase, was founded in 2010 and is based in South San Francisco, California. The firm is dedicated to discovering and advancing a pipeline of oral and respiratory biologic drug candidates, designed to address a variety of medical conditions including autoimmune, inflammatory, and metabolic diseases. Among its investigational treatments, AMT-101 stands out as the lead candidate. This orally administered, gastrointestinal (GI)-selective biologic, derived from rhIL-10, is presently in Phase II clinical trials for the management of ulcerative colitis and other related inflammatory indications. AMTI is also further developing AMT-126, another oral, GI-selective biologic that harnesses interleukin 22. This compound is currently undergoing Phase I clinical studies for the treatment of disorders stemming from impaired intestinal epithelial barrier function. The company's innovative technology platform allows for the creation and development of a broad spectrum of oral biologic therapeutic approaches, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics.

Applied Molecular Transport Inc. is headquartered in US.

Applied Molecular Transport Inc. (AMTI) stock trades at $0.26 with a market capitalization of $11.01M. The stock is valued at a price-to-earnings (P/E) ratio of -0.08, price-to-book of 0.17, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.13 and $0.84, and currently trades 69.0% below its 52-week high.

On profitability, Applied Molecular Transport Inc. generates a return on equity (ROE) of -111.78%, return on capital employed of -137.74%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.appliedmt.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides